Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-Ab™
Target-Humanized Mouse Models (HUGO-GT™)
Target-Humanized Mouse Models (CDS)
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Custom Model Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Preclinical Solutions
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic
Obesity
MASH & MASLD
Cardiovascular
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Retinal-related diseases
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Systemic Lupus Erythematosus
Drug Classification
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
iCyagen
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Company Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
Mfsd2a-CrexER Mouse
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

Mfsd2a-CrexER Mouse

Product Name
Mfsd2a-CrexER Mouse
Product ID
C002283
Strain Name
C57BL/6Cya-Mfsd2aem1(CrexER)/Cya
Background
C57BL/6Cya
Examples of Expressing Tissues/Cells
Liver cells, brain microvascular endothelial cells and other Mfsd2a-expressing cells.
Status
Live Mouse
When using this mouse strain in a publication, please cite “Mfsd2a-CrexER Mouse (Catalog C002283) were purchased from Cyagen.”
Inducible Cre Mouse Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
Standard products are sold as live mice derived from cryorecovery or expansion. Frozen materials are available upon request. Pricing and lead times depend on real-time inventory.
Inducible Cre Mouse Models

Basic Information

Related Resource
Basic Information
Gene Name
Mfsd2a
Gene Alias
NLS1, Mfsd2, 1700018O18Rik
NCBI ID
76574 (Mouse)
Chromosome
Chr 4 (Mouse)
MGI ID
MGI:1923824
Datasheet
Click here to download >>

Strain Description

Mfsd2a gene encodes major facilitator superfamily domain-containing protein 2A (MFSD2A), a cell membrane lipid transporter. In mice, Mfsd2a is highly expressed in brain microvascular endothelial cells and is an important molecule for maintaining blood-brain barrier (BBB) integrity; it is also expressed in tissues such as the liver. MFSD2A can transport long-chain fatty acids bound to lysophosphatidylcholine (LPC), especially docosahexaenoic acid (DHA), which is crucial for brain lipid homeostasis and nervous system development. Meanwhile, MFSD2A can inhibit vesicle-mediated transcytosis in brain endothelial cells, limiting non-specific transport of substances across the blood-brain barrier. Loss of Mfsd2a function can lead to increased blood-brain barrier permeability, decreased brain DHA levels, and abnormal neurodevelopment [1-2].
The Mfsd2a-CrexER mouse was constructed using gene editing technology to insert the "CrexER-WPRE-BGH pA" cassette upstream of the start codon of the mouse endogenous Mfsd2a gene. The targeting strategy disrupts endogenous Mfsd2a gene expression, causing lethality in homozygous individuals. In the absence of tamoxifen treatment, the CrexER recombinase is mainly localized in the cytoplasm; after tamoxifen induction, the CrexER recombinase can enter the nucleus and exert its recombination activity. When Mfsd2a-CrexER mice are crossed with mice carrying LoxP sites, the offspring are expected to undergo CrexER recombinase-mediated sequence recombination between LoxP sites in Mfsd2a-positive cells after tamoxifen induction. In addition, the rox sites flanking the ER (estrogen receptor) domain in the CrexER construct can be recognized by Dre recombinase. When CrexER mice are crossed with mice expressing Dre recombinase, it is expected that Dre-mediated recombination of the ER sequence between the rox sites can be achieved in Mfsd2a-positive cells, thereby releasing the Cre recombinase from ER domain regulation and enabling Cre-loxP recombination activity without the need for tamoxifen induction.
By this design, used on its own the line behaves like a tamoxifen-inducible Cre line; when combined with a line expressing Dre, recombination becomes tamoxifen-independent only in cells that both have Dre activity and express Mfsd2a, allowing intersectional labelling of cells marked by two genes.
Reference
Eser Ocak P, Ocak U, Sherchan P, Zhang JH, Tang J. Insights into major facilitator superfamily domain-containing protein-2a (Mfsd2a) in physiology and pathophysiology. What do we know so far?. J Neurosci Res.
Berger JH, Charron MJ, Silver DL. Major facilitator superfamily domain-containing protein 2a (MFSD2A) has roles in body growth, motor function, and lipid metabolism. PLoS One. 2012;7(11):e50629.

Strain Strategy

The "CrexER-WPRE-BGH pA" cassette was inserted upstream of the start codon. This strategy disrupts the normal expression and function of the Mfsd2a gene in mice.
Figure 1. Gene editing strategy of Mfsd2a-CrexER mice.
Figure 1. Gene editing strategy of Mfsd2a-CrexER mice.
Related Resource
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCompany OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2026 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research